Aster DM Quality Care Q1 FY27 Results
Analysis based on 6 articles · First reported Aug 06, 2026 · Last updated Aug 07, 2026
The strong Q1 results and successful merger are likely to boost investor confidence in Aster DM Quality Care Limited, potentially supporting its stock price. The company's improved margins and growth trajectory position it well among India's top hospital chains, attracting positive market attention.
Aster DM Quality Care Limited Limited, formed through the merger of Aster DM Healthcare Limited and Quality Care India, announced its financial results for the quarter ended June 30, 2026. On a combined proforma basis, revenue grew 20% year-over-year to INR 2,597 crore, operating EBITDA grew 30% to INR 576 crore, and operating EBITDA margin expanded to 22.2%. The merger became effective on July 1, 2026, creating a network of 39 hospitals across 28 cities with over 10,890 beds. The company reported strong performance across both legacy entities, with Aster DM Healthcare revenue up 22% and Quality Care revenue up 19%. Management, led by Executive Chairman Dr. Azad Moopen and Group CEO Varun Khanna, expressed confidence in the combined platform's growth prospects, aiming to expand to over 15,000 beds in the coming years.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard